Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It does tell me something..you like me took a position on NSPX that has a patent on Mipsagargin aka "THE CANCER GRENADE" ... Good Luck
As of last filing Sabby and affiliates owned 4,548,000 of the 11,400,000 or about 40% of the OS. Obviously with the amount of volume since the filing that % may or may not change. At these low PPS prices the market cap is low so Sabbys investment reflects the low price. One of the bullish arguments for NSPX is why would Sabby (a large fund) be interested in pennies and therefore the stock is headed for multi dollars. Sabby is all in the bio sector and has more information on the pulse of whats going on in the bio arena than most on various penny stock boards.
One of the reasons(there are others) why nspx has been discounted by investors is that nspx had the vision to take on the task of challenging one of the most deadly and incurable and seemingly impossible to cure i.e. liver cancer. The jury is still out on the drug platform but nspx is not trying to cure the common cold!
would be cool to take out week high 68!
Not much to get excited about..nspx longs have seen these bumps off over sold levels many times before. Lets see if a rally can be maintained!
You are correct..short volume is not short interest that's yet to be closed out. However a case can be made that MMs are bidding the stock down. IMO
Every transaction has a buyer and seller. Risk vs Reward! The expectation of a high reward with expending little risk is the motivating factor in the investment in penny stocks. Nobody other than the investor reaches the conclusion to take on the risk. If you cant take the lack of reward don't take on the risk!
Last press release was in 2017. You would think that if they were going to put out bogus press releases to pump the stock they would have done it by now!
Valid point flaflyersfan..However could it be that NSPX has no intention of starting the business up again and is just hanging on until they get buyers for the Intellectual Property and/or patents? As additional studies surface the case for expanded trials get more and more likely
Yes..it's all about the money! Hal Mintz and Sabby have been toying and playing games with this stock for a long time. When they decide its time to make some serious cash for themselves and their homies things will change..not before that! Be there! He knows every little thing that's going on in the sector!
Bizman2..Possible they could of sold out, there has been a lot of buying and selling since the filing but why would they... getting peanuts for their shares doesn't fit Sabby MO.
Zanias, It appears that of the 11,384,000 shares outstanding as of the latest filing, Hal Mintz (Sabby founder) and his affiliated funds own approximately 40% of those shares. He owns 1,137,260 himself as per the report!
Goodmooring..any update on Python receiving patent for the production of Thapsigargin?
Hit a hard ceiling at .01...stopped the rally cold. So you may see a repeat and try to take it out. IMO
Dress rehearsal for when some solid news come out on NSPX. MMs had a field day!
What doesn't make sense is turning 60 mil investment into 50k market cap with 4k left in the bank account. How long can this exist without some sort of major development?
Inspyr is headed for some interesting developments. The recent 10-Q filing (for some reason) gets NSPX SEC current. The cash situation is low, debts are real and obligations a fact. However, Sabby (institutional investor) is still extending support solidifying its long term interest in the company. NSPX two main drugs Adenosine and Mipsagargin have yet to attract much financial success but they are both patented and currently being studied on many fronts. Do your own DD and make your own decisions!
Like the ever ready bunny.. it keeps on going! The effort is going to pay off for nspx longs!
No brainer...at theses prices best risk reward play out there!
NSPX holds patents on a pipeline of novel therapies including Mipsagargin, A2a/A2b antogonists, A2a antagonists, A2b antagonists and A2a agonists. All are primed for further investigation, licensing and/or IND applications.The only question is when or if they will prove their worth in the very competitive and ever changing Biotech world.
I'm with you!
Strange..whats with Lewis and Clark website back up (although no updated) since it was shut down in 2018. lncpharma.com
Thanks for the informative bit of insight. Where did you come up with this info?
Ha! Comparing NSPX to AZN is a real stretch. Looks like Lincolnian is fishing for some email addresses!
Interesting..maybe some encouraging "tweets" are on the way!
Load, load, load your boat!
With the r/s complete we may or may not see further filings and stay limited pink. At some point NSPX should clue all whats up!
I don't know if "forgot" is right word but appears for some reason that they missed filling date and no NT 10-Q. NSPX has been quiet as usual!
Some believe that it is their civic duty to point out how stupid others are and to protect the investor from that very stupidity. Happens all the time..each transaction has a buyer and seller. Only listen to yourself!
the mistake is to think that nspx would hold steady after the r/s without impetus from the company! 10-Q due next week.. maybe!
With zero, zilch, nada coming in the way of info from Nspx after the r/s, shouldn’t be surprised with current stock action! No news is not always good news! Still amazed that there are still buyers at these fire sale prices!
What happened at the close? Volume busted out in last 10 min!
Not easy to put forth 60 mil and have 165k to show for all your efforts! Not a lot of confidence that the patents and the intellectual properties held from both L&C and Genspera are going to produce real value! If python gets patent to produce thapisgargan in sufficient quantities things may change!
The “D” should be dropped from the ticker in short order and then back to the “QB if it can maintain the PPS required. Going forward need news from company regarding drug development and/or Ridgeway agreement!
Not so fast my friend! When all you have are straws there is nothing wrong with grabbing a few! Maybe just maybe something will become of them! Nspx still alive after 16 yrs with multiple patents and ongoing studies!
No doubt being studied all over the world. Just feed up 140+ million in float but won’t generate much operating cash at 2 1/2 cents and low volume!
The task nspx chose was to cure or at least aid in the survival of liver and other horrid cancers! To think that this would be a slam dunk is to be naive. The stock has always been a real gamble with a high risk. Invest your money accordingly with your tolerance. All the company has now is some patents and IP ... how much they are worth remains to be seen!
I agree ..We’re now current... the r/s is behind us.. no better time to move forwards!
Follow the r/s up with some real positive news concerning the drugs and all will be fine!
what’s behind that 1.4 mil bid on wed? Got 1.3 mil filled and left!